Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
SEK 0.17
(-4.69%)
SEK 0.17
(-4.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.31 Million | -37.46 Million | -35.3 Million | -8.62 Million | -5.55 Million | -3.26 Million |
| Net Income | -12.12 Million | -37.74 Million | -41.19 Million | -7.82 Million | -4.93 Million | -3.76 Million |
| Depreciation & Amortization | 24 Thousand | 24 Thousand | 23 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.3 Million | 237 Thousand | 6.03 Million | -808 Thousand | -625 Thousand | 505 Thousand |
| Other non-cash items | 2.44 Million | 14 Thousand | -165 Thousand | 7000.00 | 52 Thousand | 3.76 Million |
| Investing Cash Flow | - | - | -119 Thousand | 1.24 Million | -1.5 Million | - |
| Investments in PPE | - | - | -119 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 1.24 Million | - | - |
| Other Investing Activities | - | - | - | -251 Thousand | -1.5 Million | - |
| Financing Cash Flow | 36.7 Million | 18.61 Million | 51.09 Million | 18.88 Million | 7.99 Million | 1.77 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -769 Thousand | - | - |
| Common Stock Issuance | 36.7 Million | 22.6 Million | 56.31 Million | 19.65 Million | 7.99 Million | 1.77 Million |
| Other Financing Activities | 36.7 Million | -3.98 Million | -5.22 Million | 18.88 Million | 7.99 Million | - |
| Accounts receivables | -520 Thousand | -242 Thousand | 1.82 Million | -2.02 Million | -599 Thousand | - |
| Accounts payables | -1.78 Million | 479 Thousand | 4.2 Million | 1.21 Million | - | - |
| Inventory | 1.78 Million | -479 Thousand | -4.2 Million | - | - | - |
| Other working capital | -1.78 Million | 479 Thousand | 4.2 Million | -1.00 | -26 Thousand | - |
| Cash at beginning of period | 9.63 Million | 28.46 Million | 12.55 Million | 1.04 Million | 107 Thousand | 1.59 Million |
| Cash at end of period | 31.92 Million | 9.63 Million | 28.46 Million | 12.55 Million | 1.04 Million | 107 Thousand |
| Capital Expenditure | - | - | -119 Thousand | - | - | - |
| Effect of forex changes on cash | -91 Thousand | 23 Thousand | 243 Thousand | - | - | - |
| Net cash flow / Change in cash | 22.29 Million | -18.83 Million | 15.91 Million | 11.5 Million | 937 Thousand | -1.48 Million |
| Free Cash Flow | -14.31 Million | -37.46 Million | -35.41 Million | -8.62 Million | -5.55 Million | -3.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -415 Thousand | -7.41 Million | -7.55 Million | -12.12 Million | -4.86 Million | 7.13 Million |
| Depreciation & Amortization | 6000.00 | 6000.00 | 6000.00 | 24 Thousand | 6000.00 | 6000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -8.18 Million | -902 Thousand | 979 Thousand | -2.3 Million | 12.77 Million | -17.52 Million |
| Other non-cash items | 8.28 Million | -1000.00 | -876 Thousand | 2.44 Million | -12.75 Million | -1000.00 |
| Investing Cash Flow | -235 Thousand | - | 1000.00 | - | - | - |
| Investments in PPE | -235 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.24 Million | 387 Thousand | 13.28 Million | 36.7 Million | - | 23.42 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.24 Million | 387 Thousand | 13.28 Million | 36.7 Million | - | 29.34 Million |
| Other Financing Activities | -211 Thousand | 387 Thousand | 13.28 Million | 36.7 Million | - | -5.92 Million |
| Accounts receivables | -8.84 Million | -94 Thousand | -36 Thousand | -520 Thousand | 16.15 Million | -17.31 Million |
| Accounts payables | 658 Thousand | -808 Thousand | 1.01 Million | -1.78 Million | -3.38 Million | -208 Thousand |
| Inventory | - | - | -621.99 Thousand | 1.78 Million | - | 1.41 Million |
| Other working capital | 658 Thousand | -808 Thousand | 622 Thousand | -1.78 Million | 1000.00 | -1.41 Million |
| Cash at beginning of period | 24 Million | 31.92 Million | 25.21 Million | 9.63 Million | 17.3 Million | 4.27 Million |
| Cash at end of period | 19.47 Million | 24 Million | 31.92 Million | 31.92 Million | 25.21 Million | 17.3 Million |
| Capital Expenditure | -235 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | -27 Thousand | 267 Thousand | -91 Thousand | -91 Thousand | - | - |
| Net cash flow / Change in cash | -4.52 Million | -7.92 Million | 6.7 Million | 22.29 Million | 7.9 Million | 13.03 Million |
| Free Cash Flow | -8.74 Million | -8.57 Million | -6.48 Million | -14.31 Million | 7.91 Million | -10.38 Million |
9926
6419
0511
QBT
TRUK
HILTON